Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
Phase 2 Completed
24 enrolled
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Phase 2 Completed
75 enrolled 12 charts
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Phase 2 Completed
56 enrolled 13 charts
SAMCO
Phase 2 Completed
132 enrolled
OPTIPRIME
Phase 2 Completed
118 enrolled
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Phase 2 Completed
16 enrolled 11 charts
SULTAN
Phase 2 Completed
20 enrolled
Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab
Phase 2 Completed
74 enrolled 15 charts
A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Phase 2 Completed
200 enrolled 23 charts
VOLFI
Phase 2 Completed
93 enrolled
PanaMa
Phase 2 Completed
387 enrolled
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
Phase 2 Completed
47 enrolled 13 charts
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors
Phase 2 Completed
285 enrolled 31 charts
Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer
Phase 2 Completed
203 enrolled 14 charts
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
Phase 2 Completed
52 enrolled 17 charts
CHRONOS
Phase 2 Completed
32 enrolled
A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer
Phase 2 Completed
14 enrolled
IMPROVE
Phase 2 Completed
151 enrolled
PIER
Phase 2 Completed
34 enrolled
S10PANI01
Phase 2 Completed
32 enrolled
OPALO
Phase 2 Completed
20 enrolled
Chemoradiation and Panitumumab for Esophageal Cancer
Phase 2 Completed
78 enrolled
MEGA
Phase 2 Completed
162 enrolled
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Phase 2 Completed
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Phase 2 Completed
35 enrolled 7 charts
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Phase 2 Completed
72 enrolled
Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer
Phase 2 Completed
154 enrolled 18 charts
SAPPHIRE
Phase 2 Completed
164 enrolled 29 charts
A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
Phase 2 Completed
11 enrolled
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Phase 2 Completed
28 enrolled 11 charts
VECTITAX
Phase 2 Completed
40 enrolled
MetAction
Phase 2 Completed
50 enrolled
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Phase 2 Completed
266 enrolled 17 charts
PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
Phase 2 Completed
113 enrolled 18 charts
Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer
Phase 2 Completed
153 enrolled 18 charts
VITAL
Phase 2 Completed
58 enrolled
PULSE
Phase 2 Completed
78 enrolled
NEOPECX
Phase 2 Completed
171 enrolled
PiCCA
Phase 2 Completed
93 enrolled
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
Phase 2 Completed
46 enrolled 6 charts
ULTRA
Phase 2 Completed
72 enrolled
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Phase 2 Completed
20 enrolled 11 charts
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
104 enrolled 10 charts
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery
Phase 2 Completed
52 enrolled 9 charts
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
152 enrolled 18 charts
GOC-B-P
Phase 2 Completed
88 enrolled
Phase II Study of Irinotecan and Panitumumab
Phase 2 Completed
24 enrolled 10 charts
Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
Phase 2 Completed
70 enrolled 8 charts
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
Phase 2 Completed
70 enrolled 15 charts
STEPP
Phase 2 Completed
95 enrolled 23 charts